Epizyme, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Epizyme, Inc. has filed 829 SEC EDGAR filings since 22 Mar 2013

SEC filing history

Showing 626-650 of 829 matching filings.

Per page
25
Current page
26
4

FORM 4 SUBMISSION

Filing date
03 Oct 2014
Reporting date
01 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2014
Reporting date
01 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
01 Oct 2014
Reporting date
01 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35945

FORM 8-K

Filing date
30 Sep 2014
Reporting date
26 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Sep 2014
Reporting date
22 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Sep 2014
Reporting date
22 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Sep 2014
Reporting date
15 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Sep 2014
Reporting date
11 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
15 Sep 2014
Reporting date
11 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Sep 2014
Reporting date
04 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
05 Sep 2014
Reporting date
26 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
05 Sep 2014
Reporting date
26 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Sep 2014
Reporting date
02 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Sep 2014
Reporting date
02 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35945

FORM 8-K

Filing date
02 Sep 2014
Reporting date
02 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Aug 2014
Reporting date
26 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
28 Aug 2014
Reporting date
25 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Aug 2014
Reporting date
26 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
28 Aug 2014
Reporting date
25 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87481

SC 13D/A

Filing date
26 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Aug 2014
Reporting date
21 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Aug 2014
Reporting date
21 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Aug 2014
Reporting date
22 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87481

EPIZYME, INC.

Filing date
21 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Aug 2014
Reporting date
15 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .